NCT05237986View on ClinicalTrials.gov

Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy

RecruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

June 23, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2027

Conditions

LymphomaLeukemia

Trial Locations (3)

20892

RECRUITING

National Institutes of Health Clinical Center, Bethesda

90027

RECRUITING

Children s Hospital of Los Angeles, Los Angeles

98105

RECRUITING

Seattle Children s Hospital, Seattle

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT05237986 - Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy | Biotech Hunter | Biotech Hunter